Kavyani Zeynab, Dehghan Parvin, Khani Mostafa, Khalafi Mousa, Rosenkranz Sara K
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Biochemistry and Nutrition Therapy, School of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran.
Front Nutr. 2023 Mar 1;10:1102862. doi: 10.3389/fnut.2023.1102862. eCollection 2023.
The purpose of this study was to evaluate the independent and combined effects of camelina sativa oil and high-intensity interval training (HIIT) on liver function, and metabolic outcomes in streptozotocin-induced diabetic rats.
Forty male Wistar rats were randomly assigned to five equal groups (8 per group): Normal control (NC), diabetic control (DC), diabetic + camelina sativa oil (300 mg/kg by oral gavage per day; D + CSO), diabetic + HIIT (running on a treadmill 5 days/week for 8 weeks; D + HIIT), diabetic + camelina sativa oil + HIIT (D + CSO + HIIT).
In all three intervention groups (D + CSO, D + HIIT, and D + CSO + HIIT) compared to the DC, hepatic TNF-α, MDA, and histopathology markers, decreased and hepatic PGC-1α, and PPAR-γ increased (p < 0.05). However, the effect of D + CSO was greater than D + HIIT alone. Hepatic TG decreased significantly in D + HIIT and D + CSO + HIIT compared to other groups ( < 0.001). Fasting plasma glucose in all three intervention groups (D + CSO, D + HIIT, and D + CSO + HIIT) and HOMA-IR in D + CSO and D + CSO + HIIT were decreased compared to DC ( < 0.001). Only hepatic TAC and fasting plasma insulin remained unaffected in the three diabetic groups ( < 0.001). Overall, D + CSO + HIIT had the largest effect on all outcomes.
At the doses and treatment duration used in the current study, combination of CSO and HIIT was beneficial for reducing liver function and metabolic outcomes other than CSO and HIIT alone.
本研究旨在评估荠蓝籽油和高强度间歇训练(HIIT)对链脲佐菌素诱导的糖尿病大鼠肝功能和代谢结果的独立及联合作用。
40只雄性Wistar大鼠随机分为五组,每组8只:正常对照组(NC)、糖尿病对照组(DC)、糖尿病 + 荠蓝籽油组(每天经口灌胃300毫克/千克;D + CSO)、糖尿病 + HIIT组(每周在跑步机上跑步5天,持续8周;D + HIIT)、糖尿病 + 荠蓝籽油 + HIIT组(D + CSO + HIIT)。
与DC组相比,所有三个干预组(D + CSO、D + HIIT和D + CSO + HIIT)的肝脏肿瘤坏死因子-α(TNF-α)、丙二醛(MDA)和组织病理学标志物均降低,肝脏过氧化物酶体增殖物激活受体γ共激活因子-1α(PGC-1α)和过氧化物酶体增殖物激活受体γ(PPAR-γ)增加(p < 0.05)。然而,D + CSO的效果大于单独的D + HIIT。与其他组相比,D + HIIT和D + CSO + HIIT组的肝脏甘油三酯(TG)显著降低(< 0.001)。与DC组相比,所有三个干预组(D + CSO、D + HIIT和D + CSO + HIIT)的空腹血糖以及D + CSO和D + CSO + HIIT组的稳态模型评估胰岛素抵抗(HOMA-IR)均降低(< 0.001)。在三个糖尿病组中,仅肝脏总抗氧化能力(TAC)和空腹血浆胰岛素未受影响(< 0.001)。总体而言,D + CSO + HIIT对所有结果的影响最大。
在本研究使用的剂量和治疗持续时间下,CSO和HIIT联合使用比单独使用CSO和HIIT更有利于降低肝功能和改善代谢结果。